(LYNCHBURG, Va. – June 5, 2018) – BWX Technologies, Inc. (NYSE:BWXT) Senior Vice President and Chief Financial Officer David Black will be presenting at the
(LYNCHBURG, Va. – May 10, 2018) – BWX Technologies, Inc. (NYSE:BWXT) announced today that Joel W. Duling has been appointed to succeed retiring BWXT Nuclear
BWX Technologies, Inc. (NYSE:BWXT) (“BWXT” or the “Company”) announced today that it has developed an innovative and unique process to manufacture molybdenum-99 (Mo-99) that will
Highlights: • 1Q18 GAAP EPS of $0.66, up 20%; 1Q18 non-GAAP EPS of $0.67, up 22%• Strong revenue growth of 7% with expanding segment margins•
BWX Technologies, Inc. (NYSE:BWXT) announced today that its subsidiary BWXT Canada Ltd. (BWXT Canada) has been awarded a contract valued at approximately CA$642 million from
BWX Technologies, Inc. (NYSE:BWXT) (“BWXT” or the “Company”) announced today that it has signed a definitive agreement to acquire Sotera Health’s Nordion medical isotope business.
LYNCHBURG, Virginia – BWX Technologies, Inc. (NYSE:BWXT) announced today that the U.S. Naval Nuclear Propulsion Program has exercised contract options with BWXT subsidiary Nuclear Fuel
(LYNCHBURG, Va. – March 19, 2018) – BWX Technologies, Inc. (NYSE:BWXT) President and Chief Executive Officer Rex D. Geveden will be presenting at the Bank
(PETERBOROUGH, Ontario – March 12, 2018) – BWX Technologies, Inc. (NYSE:BWXT) announced today that its subsidiary BWXT Nuclear Energy Canada Inc. (BWXT NEC) has been
Highlights: • 2017 GAAP EPS of $1.47; non-GAAP EPS of $2.05• 2017 consolidated revenue growth of 9%• Robust consolidated backlog of $4.0 billion• Announces 45%